BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $826,156 | -1.4% | 850 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $838,296 | +254.3% | 850 | +240.0% | 0.01% | +200.0% |
| Q1 2023 | $236,618 | -11.2% | 250 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $266,456 | -40.5% | 250 | -44.4% | 0.00% | -33.3% |
| Q3 2022 | $448,000 | -43.6% | 450 | -43.8% | 0.00% | -57.1% |
| Q2 2022 | $794,000 | -1.5% | 800 | 0.0% | 0.01% | +40.0% |
| Q1 2022 | $806,000 | -4.3% | 800 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $842,000 | +2.4% | 800 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $822,000 | -1.6% | 800 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $835,000 | +0.6% | 800 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $830,000 | -3.9% | 800 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $864,000 | -73.0% | 800 | -69.2% | 0.01% | -79.4% |
| Q2 2020 | $3,198,000 | +2.6% | 2,600 | -13.3% | 0.03% | -2.9% |
| Q1 2020 | $3,117,000 | -2.2% | 3,000 | 0.0% | 0.04% | +2.9% |
| Q4 2019 | $3,188,000 | +7.7% | 3,000 | 0.0% | 0.03% | -12.8% |
| Q3 2019 | $2,959,000 | -4.9% | 3,000 | 0.0% | 0.04% | 0.0% |
| Q2 2019 | $3,113,000 | +1361.5% | 3,000 | +1400.0% | 0.04% | +1200.0% |
| Q3 2018 | $213,000 | +4.4% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $204,000 | -46.0% | 200 | -50.0% | 0.00% | -50.0% |
| Q1 2018 | $378,000 | +26.0% | 400 | +33.3% | 0.01% | +20.0% |
| Q4 2017 | $300,000 | +47.8% | 300 | +50.0% | 0.01% | +25.0% |
| Q3 2017 | $203,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
| Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
| PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
| Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
| MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
| IRON Financial LLC | 275,000 | $295,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |